Literature DB >> 22956554

Mechanisms in endocrinology: Heart failure and thyroid dysfunction.

Bernadette Biondi1.   

Abstract

CONTEXT: Heart failure (HF) is a major cause of morbidity and mortality in Europe and in the United States. The aim of this review article was to assess the results of the prospective studies that evaluated the risk of HF in patients with overt and subclinical thyroid disease and discuss the mechanism of this dysfunction. EVIDENCE ACQUISITION: Reports published with the following search terms were searched:, thyroid, hypothyroidism, hyperthyroidism, subclinical hyperthyroidism, subclinical hypothyroidism, levothyroxine, triiodothyronine, antithyroid drugs, radioiodine, deiodinases, clinical symptoms, heart rate, HF, systolic function, diastolic function, systemic vascular resistance, endothelial function, amiodarone and atrial fibrillation. The investigation was restricted to reports published in English. EVIDENCE SYNTHESIS: The outcome of this analysis suggests that patients with untreated overt thyroid dysfunction are at increased risk of HF. Moreover, persistent subclinical thyroid dysfunction is associated with the development of HF in patients with serum TSH <0.1 or > 10 mU/l.
CONCLUSIONS: The timely recognition and effective treatment of cardiac symptoms in patients with thyroid dysfunction is mandatory because the prognosis of HF may be improved with the appropriate treatment of thyroid dysfunction.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22956554     DOI: 10.1530/EJE-12-0627

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  80 in total

1.  Left ventricular systolic intraventricular flow field assessment in hyperthyroidism patients using vector flow mapping.

Authors:  Bin-Yu Zhou; Jing Wang; Ming-Xing Xie; Man-Wei Liu; Qing Lv
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-07-31

2.  Nonthyroidal Illness Syndrome in Cardiac Illness Involves Elevated Concentrations of 3,5-Diiodothyronine and Correlates with Atrial Remodeling.

Authors:  Johannes W Dietrich; Patrick Müller; Fabian Schiedat; Markus Schlömicher; Justus Strauch; Apostolos Chatzitomaris; Harald H Klein; Andreas Mügge; Josef Köhrle; Eddy Rijntjes; Ina Lehmphul
Journal:  Eur Thyroid J       Date:  2015-05-23

Review 3.  Thyroid hormone therapy for subclinical hypothyroidism.

Authors:  Flavia Magri; Luca Chiovato; Laura Croce; Mario Rotondi
Journal:  Endocrine       Date:  2019-10-15       Impact factor: 3.633

4.  Iodinated contrast-induced thyrotoxicosis.

Authors:  Paul Dunne; Nisha Kaimal; John MacDonald; Akheel A Syed
Journal:  CMAJ       Date:  2012-11-12       Impact factor: 8.262

5.  Clinical outcomes of patients with hypothyroidism undergoing percutaneous coronary intervention.

Authors:  Ming Zhang; Jaskanwal D S Sara; Yasushi Matsuzawa; Hossein Gharib; Malcolm R Bell; Rajiv Gulati; Lilach O Lerman; Amir Lerman
Journal:  Eur Heart J       Date:  2016-01-12       Impact factor: 29.983

6.  A placebo-controlled, blinded and randomised study on the effects of recombinant human thyrotropin on quality of life in the treatment of thyroid cancer.

Authors:  Birte Nygaard; Lars Bastholt; Finn Noe Bennedbæk; Tobias Wirenfeldt Klausen; Jens Bentzen
Journal:  Eur Thyroid J       Date:  2013-09-07

Review 7.  Pulmonary hypertension in thyroid diseases.

Authors:  Pietro Scicchitano; Ilaria Dentamaro; Francesco Tunzi; Gabriella Ricci; Santa Carbonara; Fiorella Devito; Annapaola Zito; Anna Ciampolillo; Marco Matteo Ciccone
Journal:  Endocrine       Date:  2016-03-19       Impact factor: 3.633

8.  Evidence and controversies regarding the screening for subclinical hypothyroidism in patients with cardiovascular disease.

Authors:  Baris Gencer; Nicolas Rodondi
Journal:  J Thorac Dis       Date:  2016-06       Impact factor: 2.895

Review 9.  Central hypothyroidism and its role for cardiovascular risk factors in hypopituitary patients.

Authors:  Ulla Feldt-Rasmussen; Marianne Klose
Journal:  Endocrine       Date:  2016-08-01       Impact factor: 3.633

10.  Comparison of Mortality and Nonfatal Cardiovascular Events in Adults With Atrial Fibrillation With Versus Without Levothyroxine Treatment.

Authors:  Per Wändell; Axel C Carlsson; Martin J Holzmann; Johan Ärnlöv; Jan Sundquist; Kristina Sundquist
Journal:  Am J Cardiol       Date:  2017-08-30       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.